+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients

Journal of Acquired Immune Deficiency Syndromes 45(3): 348-354
The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients
A retrospective costing study of 212 patients enrolled in a nongovernmental organization-supported public sector antiretroviral treatment (ART) program near Cape Town, South Africa was performed from a health care system perspective. gamma-Regression was used to analyze total costs in 3 periods: Pre-ART (median length = 30 days), first 48 weeks on ART (Year One), and 49 to 112 weeks on ART (Year Two). Average cost per patient Pre-ART was $404. Average cost per patient-year of observation was $2502 in Year One and $1372 in Year Two. The proportion of costs attributable to hospital care fell from 70% Pre-ART to 24% by Year Two; the proportion attributable to ART rose from 31% in Year One to 55% in Year Two. In multivariate analysis, Pre-ART and Year One costs were significantly lower for asymptornatic patients compared with those with AIDS. Costs were significantly higher for those who died Pre-ART or in Year One. In Year Two, only week 48 CD4 cell count and being male were significantly associated with lower costs. This analysis suggests that the total cost of treatment for patients on ART falls by almost half after I year, largely attributable to a reduction in hospital costs.

(PDF same-day service: $19.90)

Accession: 017377532

PMID: 17496562

DOI: 10.1097/QAI.0b013e3180691115

Related references

Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa. Journal of Acquired Immune Deficiency Syndromes 61(3): E25-E32, 2013

An analysis of the cost of incomplete abortion to the public health sector in South Africa--1994. South African Medical Journal 87(4): 442-447, 1997

Public sector antiretroviral treatment programme in South Africa: health care workers' attention to mental health problems. Aids Care 27(4): 458-465, 2015

Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. Aids 12(13): 1675-1682, 1998

A cost analysis of a hospital-based palliative care outreach program: implications for expanding public sector palliative care in South Africa. Journal of Pain and Symptom Management 41(6): 1015-1024, 2011

Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa. Journal of Acquired Immune Deficiency Syndromes 69(5): 576-584, 2015

Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa. Bmc Infectious Diseases 16(): 43-43, 2016

Cost-effectiveness of staff and workload profiles in retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa. Aids Care 23(9): 1146-1153, 2011

Traditional, complementary and alternative medicine use by HIV patients a decade after public sector antiretroviral therapy roll out in South Africa: a cross sectional study. Bmc Complementary and Alternative Medicine 16(): 128-128, 2016

Provision of antiretroviral therapy to children within the public sector of South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(9): 905-911, 2008